Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1956 1
1963 3
1967 1
1968 1
1970 2
1971 2
1972 1
1974 1
1988 4
1989 6
1990 6
1991 7
1992 5
1993 5
1994 3
1995 8
1996 5
1997 1
1998 10
1999 10
2000 11
2001 13
2002 16
2003 13
2004 10
2005 14
2006 9
2007 11
2008 12
2009 21
2010 23
2011 22
2012 26
2013 21
2014 20
2015 17
2016 12
2017 12
2018 12
2019 5
2020 5
2021 16
2022 8
2023 3
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

382 results

Results by year

Filters applied: . Clear all
Page 1
Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis.
Sanyal AJ, Chalasani N, Kowdley KV, McCullough A, Diehl AM, Bass NM, Neuschwander-Tetri BA, Lavine JE, Tonascia J, Unalp A, Van Natta M, Clark J, Brunt EM, Kleiner DE, Hoofnagle JH, Robuck PR; NASH CRN. Sanyal AJ, et al. Among authors: brunt em. N Engl J Med. 2010 May 6;362(18):1675-85. doi: 10.1056/NEJMoa0907929. Epub 2010 Apr 28. N Engl J Med. 2010. PMID: 20427778 Free PMC article. Clinical Trial.
Nonalcoholic fatty liver disease.
Brunt EM, Wong VW, Nobili V, Day CP, Sookoian S, Maher JJ, Bugianesi E, Sirlin CB, Neuschwander-Tetri BA, Rinella ME. Brunt EM, et al. Nat Rev Dis Primers. 2015 Dec 17;1:15080. doi: 10.1038/nrdp.2015.80. Nat Rev Dis Primers. 2015. PMID: 27188459 Free article. Review.
Design and validation of a histological scoring system for nonalcoholic fatty liver disease.
Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, Ferrell LD, Liu YC, Torbenson MS, Unalp-Arida A, Yeh M, McCullough AJ, Sanyal AJ; Nonalcoholic Steatohepatitis Clinical Research Network. Kleiner DE, et al. Among authors: brunt em. Hepatology. 2005 Jun;41(6):1313-21. doi: 10.1002/hep.20701. Hepatology. 2005. PMID: 15915461
Silymarin in non-cirrhotics with non-alcoholic steatohepatitis: A randomized, double-blind, placebo controlled trial.
Navarro VJ, Belle SH, D'Amato M, Adfhal N, Brunt EM, Fried MW, Reddy KR, Wahed AS, Harrison S; Silymarin in NASH and C Hepatitis (SyNCH) Study Group. Navarro VJ, et al. Among authors: brunt em. PLoS One. 2019 Sep 19;14(9):e0221683. doi: 10.1371/journal.pone.0221683. eCollection 2019. PLoS One. 2019. PMID: 31536511 Free PMC article. Clinical Trial.
The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology.
Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, Charlton M, Sanyal AJ; American Gastroenterological Association; American Association for the Study of Liver Diseases; American College of Gastroenterologyh. Chalasani N, et al. Among authors: brunt em. Gastroenterology. 2012 Jun;142(7):1592-609. doi: 10.1053/j.gastro.2012.04.001. Epub 2012 May 15. Gastroenterology. 2012. PMID: 22656328 No abstract available.
Nonalcoholic steatohepatitis.
Brunt EM. Brunt EM. Semin Liver Dis. 2004 Feb;24(1):3-20. doi: 10.1055/s-2004-823098. Semin Liver Dis. 2004. PMID: 15085483 Review.
382 results